Lunai Bioworks Stock (NASDAQ:LNAI)
Previous Close
$1.29
52W Range
$1.13 - $21.00
50D Avg
$2.13
200D Avg
$4.96
Market Cap
$22.28M
Avg Vol (3M)
$215.53K
Beta
0.39
Div Yield
-
LNAI Company Profile
A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.
Industry
Biotechnology
Sector
Healthcare
Exchange
NASDAQ
ADR
-
Country
US
Employees
-
IPO Date
Sep 30, 2025
Website
-